CN117377459A - 用于清洁角蛋白材料和/或从角蛋白材料卸妆的组合物 - Google Patents
用于清洁角蛋白材料和/或从角蛋白材料卸妆的组合物 Download PDFInfo
- Publication number
- CN117377459A CN117377459A CN202180098636.2A CN202180098636A CN117377459A CN 117377459 A CN117377459 A CN 117377459A CN 202180098636 A CN202180098636 A CN 202180098636A CN 117377459 A CN117377459 A CN 117377459A
- Authority
- CN
- China
- Prior art keywords
- composition
- alcohol
- sodium
- keratin materials
- glutamate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 110
- 102000011782 Keratins Human genes 0.000 title claims abstract description 34
- 108010076876 Keratins Proteins 0.000 title claims abstract description 34
- 239000000463 material Substances 0.000 title claims abstract description 34
- 238000004140 cleaning Methods 0.000 title description 3
- 229910052751 metal Inorganic materials 0.000 claims abstract description 29
- 239000002184 metal Substances 0.000 claims abstract description 29
- 150000001413 amino acids Chemical class 0.000 claims abstract description 27
- 150000003839 salts Chemical class 0.000 claims abstract description 26
- 239000004094 surface-active agent Substances 0.000 claims abstract description 25
- 229920006395 saturated elastomer Polymers 0.000 claims abstract description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 17
- 239000008346 aqueous phase Substances 0.000 claims abstract description 10
- 238000002560 therapeutic procedure Methods 0.000 claims abstract description 5
- 239000011734 sodium Substances 0.000 claims description 17
- 229910052708 sodium Inorganic materials 0.000 claims description 17
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 16
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 15
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 15
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 15
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 claims description 14
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 10
- 229910052739 hydrogen Inorganic materials 0.000 claims description 10
- 239000001257 hydrogen Substances 0.000 claims description 10
- 229920005862 polyol Polymers 0.000 claims description 10
- 150000003077 polyols Chemical class 0.000 claims description 10
- 239000011591 potassium Substances 0.000 claims description 10
- 229910052700 potassium Inorganic materials 0.000 claims description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 9
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 claims description 9
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 8
- 239000002280 amphoteric surfactant Substances 0.000 claims description 8
- IKGKWKGYFJBGQJ-UHFFFAOYSA-M sodium;2-(dodecanoylamino)acetate Chemical compound [Na+].CCCCCCCCCCCC(=O)NCC([O-])=O IKGKWKGYFJBGQJ-UHFFFAOYSA-M 0.000 claims description 8
- 229960000541 cetyl alcohol Drugs 0.000 claims description 7
- 108700004121 sarkosyl Proteins 0.000 claims description 7
- 229940065859 sodium cocoyl glycinate Drugs 0.000 claims description 7
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 claims description 7
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 claims description 6
- 125000000217 alkyl group Chemical group 0.000 claims description 6
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 claims description 6
- 229940079779 disodium cocoyl glutamate Drugs 0.000 claims description 6
- 235000011187 glycerol Nutrition 0.000 claims description 6
- 229940045944 sodium lauroyl glutamate Drugs 0.000 claims description 6
- 229940045885 sodium lauroyl sarcosinate Drugs 0.000 claims description 6
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 claims description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 5
- 150000001450 anions Chemical class 0.000 claims description 5
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 5
- 150000001768 cations Chemical class 0.000 claims description 5
- 229940082500 cetostearyl alcohol Drugs 0.000 claims description 5
- 239000006071 cream Substances 0.000 claims description 5
- 239000000839 emulsion Substances 0.000 claims description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 5
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 claims description 5
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 claims description 5
- 229940079988 potassium cocoyl glycinate Drugs 0.000 claims description 5
- 229940079781 sodium cocoyl glutamate Drugs 0.000 claims description 5
- 229940012831 stearyl alcohol Drugs 0.000 claims description 5
- TUBPSFQENHCYBW-HVDRVSQOSA-N (2s)-2-aminopentanedioic acid;2-[bis(2-hydroxyethyl)amino]ethanol Chemical compound OC(=O)[C@@H](N)CCC(O)=O.OCCN(CCO)CCO TUBPSFQENHCYBW-HVDRVSQOSA-N 0.000 claims description 4
- 239000002202 Polyethylene glycol Substances 0.000 claims description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 4
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical group CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 claims description 4
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims description 4
- 229960000735 docosanol Drugs 0.000 claims description 4
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- BTFJIXJJCSYFAL-UHFFFAOYSA-N icosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 claims description 4
- REIUXOLGHVXAEO-UHFFFAOYSA-N pentadecan-1-ol Chemical compound CCCCCCCCCCCCCCCO REIUXOLGHVXAEO-UHFFFAOYSA-N 0.000 claims description 4
- 229920001223 polyethylene glycol Polymers 0.000 claims description 4
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 claims description 4
- 229940048912 triethanolamine cocoyl glutamate Drugs 0.000 claims description 4
- 238000005406 washing Methods 0.000 claims description 4
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 3
- RWLALWYNXFYRGW-UHFFFAOYSA-N 2-Ethyl-1,3-hexanediol Chemical compound CCCC(O)C(CC)CO RWLALWYNXFYRGW-UHFFFAOYSA-N 0.000 claims description 3
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 claims description 3
- 229960005082 etohexadiol Drugs 0.000 claims description 3
- 229960005150 glycerol Drugs 0.000 claims description 3
- 229940051250 hexylene glycol Drugs 0.000 claims description 3
- 229940045898 sodium stearoyl glutamate Drugs 0.000 claims description 3
- KDHFCTLPQJQDQI-BDQAORGHSA-M sodium;(4s)-4-amino-5-octadecanoyloxy-5-oxopentanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC(=O)OC(=O)[C@@H](N)CCC([O-])=O KDHFCTLPQJQDQI-BDQAORGHSA-M 0.000 claims description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 2
- XFRVVPUIAFSTFO-UHFFFAOYSA-N 1-Tridecanol Chemical compound CCCCCCCCCCCCCO XFRVVPUIAFSTFO-UHFFFAOYSA-N 0.000 claims description 2
- 125000001183 hydrocarbyl group Chemical group 0.000 claims description 2
- 229910021645 metal ion Inorganic materials 0.000 claims description 2
- 229940043348 myristyl alcohol Drugs 0.000 claims description 2
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 2
- 229940087291 tridecyl alcohol Drugs 0.000 claims description 2
- IWIUXJGIDSGWDN-UQKRIMTDSA-M sodium;(2s)-2-(dodecanoylamino)pentanedioate;hydron Chemical compound [Na+].CCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC(O)=O IWIUXJGIDSGWDN-UQKRIMTDSA-M 0.000 claims 1
- 229940024606 amino acid Drugs 0.000 description 24
- 235000001014 amino acid Nutrition 0.000 description 24
- 239000000047 product Substances 0.000 description 18
- -1 carboxylate salt Chemical class 0.000 description 17
- 239000006260 foam Substances 0.000 description 17
- 229940083542 sodium Drugs 0.000 description 14
- 239000003921 oil Substances 0.000 description 13
- 235000019198 oils Nutrition 0.000 description 13
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 10
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 10
- 239000002253 acid Substances 0.000 description 10
- 229940009098 aspartate Drugs 0.000 description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 238000005187 foaming Methods 0.000 description 7
- JQAACYUZYRBHGG-UHFFFAOYSA-L magnesium pidolate Chemical compound [Mg+2].[O-]C(=O)C1CCC(=O)N1.[O-]C(=O)C1CCC(=O)N1 JQAACYUZYRBHGG-UHFFFAOYSA-L 0.000 description 7
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 6
- HWUINYGRRJTXGE-UTLKBRERSA-L disodium;(2s)-2-(dodecanoylamino)pentanedioate Chemical compound [Na+].[Na+].CCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC([O-])=O HWUINYGRRJTXGE-UTLKBRERSA-L 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 229910000019 calcium carbonate Inorganic materials 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 150000004820 halides Chemical class 0.000 description 5
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 5
- 210000002374 sebum Anatomy 0.000 description 5
- OCUCCJIRFHNWBP-IYEMJOQQSA-L Copper gluconate Chemical class [Cu+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OCUCCJIRFHNWBP-IYEMJOQQSA-L 0.000 description 4
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 4
- 108010077895 Sarcosine Proteins 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 239000010949 copper Substances 0.000 description 4
- KCIDZIIHRGYJAE-YGFYJFDDSA-L dipotassium;[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] phosphate Chemical compound [K+].[K+].OC[C@H]1O[C@H](OP([O-])([O-])=O)[C@H](O)[C@@H](O)[C@H]1O KCIDZIIHRGYJAE-YGFYJFDDSA-L 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 239000001755 magnesium gluconate Substances 0.000 description 4
- 235000015778 magnesium gluconate Nutrition 0.000 description 4
- 229960003035 magnesium gluconate Drugs 0.000 description 4
- IAKLPCRFBAZVRW-XRDLMGPZSA-L magnesium;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate;hydrate Chemical compound O.[Mg+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O IAKLPCRFBAZVRW-XRDLMGPZSA-L 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 150000007524 organic acids Chemical class 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- OWVLYQRCCIEOPF-QHTZZOMLSA-L zinc;(2s)-5-oxopyrrolidine-2-carboxylate Chemical compound [Zn+2].[O-]C(=O)[C@@H]1CCC(=O)N1.[O-]C(=O)[C@@H]1CCC(=O)N1 OWVLYQRCCIEOPF-QHTZZOMLSA-L 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 3
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 3
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 description 3
- 229940000635 beta-alanine Drugs 0.000 description 3
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-aminopropionic acid Natural products NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 239000001110 calcium chloride Substances 0.000 description 3
- 229910001628 calcium chloride Inorganic materials 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 235000015165 citric acid Nutrition 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 229940108928 copper Drugs 0.000 description 3
- 229940108925 copper gluconate Drugs 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 238000011038 discontinuous diafiltration by volume reduction Methods 0.000 description 3
- 230000014509 gene expression Effects 0.000 description 3
- 229940070808 lauroyl aspartate Drugs 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- UEGPKNKPLBYCNK-UHFFFAOYSA-L magnesium acetate Chemical compound [Mg+2].CC([O-])=O.CC([O-])=O UEGPKNKPLBYCNK-UHFFFAOYSA-L 0.000 description 3
- 239000011654 magnesium acetate Substances 0.000 description 3
- 235000011285 magnesium acetate Nutrition 0.000 description 3
- 229940069446 magnesium acetate Drugs 0.000 description 3
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 3
- 239000001095 magnesium carbonate Substances 0.000 description 3
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 3
- 235000014380 magnesium carbonate Nutrition 0.000 description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 3
- 229960003390 magnesium sulfate Drugs 0.000 description 3
- 235000019341 magnesium sulphate Nutrition 0.000 description 3
- JQAACYUZYRBHGG-QHTZZOMLSA-L magnesium;(2s)-5-oxopyrrolidine-2-carboxylate Chemical compound [Mg+2].[O-]C(=O)[C@@H]1CCC(=O)N1.[O-]C(=O)[C@@H]1CCC(=O)N1 JQAACYUZYRBHGG-QHTZZOMLSA-L 0.000 description 3
- 150000007522 mineralic acids Chemical class 0.000 description 3
- CXMXRPHRNRROMY-UHFFFAOYSA-N sebacic acid Chemical compound OC(=O)CCCCCCCCC(O)=O CXMXRPHRNRROMY-UHFFFAOYSA-N 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000008399 tap water Substances 0.000 description 3
- 235000020679 tap water Nutrition 0.000 description 3
- 239000011670 zinc gluconate Substances 0.000 description 3
- 235000011478 zinc gluconate Nutrition 0.000 description 3
- 229960000306 zinc gluconate Drugs 0.000 description 3
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 2
- ILKFYYOGOCVZRU-UHFFFAOYSA-N 3-(dodecanoylamino)propanoic acid Chemical compound CCCCCCCCCCCC(=O)NCCC(O)=O ILKFYYOGOCVZRU-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 2
- ZCCIPPOKBCJFDN-UHFFFAOYSA-N calcium nitrate Chemical compound [Ca+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ZCCIPPOKBCJFDN-UHFFFAOYSA-N 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 150000001805 chlorine compounds Chemical class 0.000 description 2
- 150000001860 citric acid derivatives Chemical class 0.000 description 2
- QTHQYNCAWSGBCE-UHFFFAOYSA-N docosanoyl chloride Chemical compound CCCCCCCCCCCCCCCCCCCCCC(Cl)=O QTHQYNCAWSGBCE-UHFFFAOYSA-N 0.000 description 2
- NQGIJDNPUZEBRU-UHFFFAOYSA-N dodecanoyl chloride Chemical compound CCCCCCCCCCCC(Cl)=O NQGIJDNPUZEBRU-UHFFFAOYSA-N 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- HHLFWLYXYJOTON-UHFFFAOYSA-N glyoxylic acid Chemical compound OC(=O)C=O HHLFWLYXYJOTON-UHFFFAOYSA-N 0.000 description 2
- ARBOVOVUTSQWSS-UHFFFAOYSA-N hexadecanoyl chloride Chemical compound CCCCCCCCCCCCCCCC(Cl)=O ARBOVOVUTSQWSS-UHFFFAOYSA-N 0.000 description 2
- BXZBGYJQEFZICM-UHFFFAOYSA-N icosanoyl chloride Chemical compound CCCCCCCCCCCCCCCCCCCC(Cl)=O BXZBGYJQEFZICM-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 229960001708 magnesium carbonate Drugs 0.000 description 2
- YIXJRHPUWRPCBB-UHFFFAOYSA-N magnesium nitrate Chemical compound [Mg+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O YIXJRHPUWRPCBB-UHFFFAOYSA-N 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 125000001419 myristoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- WTBAHSZERDXKKZ-UHFFFAOYSA-N octadecanoyl chloride Chemical compound CCCCCCCCCCCCCCCCCC(Cl)=O WTBAHSZERDXKKZ-UHFFFAOYSA-N 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 229940071089 sarcosinate Drugs 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- LWBVAHQZGAKXPU-BOXHHOBZSA-M sodium;(4s)-4-amino-5-octadecoxy-5-oxopentanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCCOC(=O)[C@@H](N)CCC([O-])=O LWBVAHQZGAKXPU-BOXHHOBZSA-M 0.000 description 2
- AUHKUMFBHOJIMU-UHFFFAOYSA-M sodium;2-[hexadecanoyl(methyl)amino]acetate Chemical compound [Na+].CCCCCCCCCCCCCCCC(=O)N(C)CC([O-])=O AUHKUMFBHOJIMU-UHFFFAOYSA-M 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- ONDPHDOFVYQSGI-UHFFFAOYSA-N zinc nitrate Chemical compound [Zn+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ONDPHDOFVYQSGI-UHFFFAOYSA-N 0.000 description 2
- WHOZNOZYMBRCBL-OUKQBFOZSA-N (2E)-2-Tetradecenal Chemical compound CCCCCCCCCCC\C=C\C=O WHOZNOZYMBRCBL-OUKQBFOZSA-N 0.000 description 1
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- MLQBTMWHIOYKKC-KTKRTIGZSA-N (z)-octadec-9-enoyl chloride Chemical compound CCCCCCCC\C=C/CCCCCCCC(Cl)=O MLQBTMWHIOYKKC-KTKRTIGZSA-N 0.000 description 1
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- ACCAIGJKLCJFHP-UQKRIMTDSA-N 2-[bis(2-hydroxyethyl)amino]ethanol;(2s)-2-(dodecanoylamino)pentanedioic acid Chemical compound OCCN(CCO)CCO.CCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC(O)=O ACCAIGJKLCJFHP-UQKRIMTDSA-N 0.000 description 1
- GRYDXAUFDMVZNZ-UQKRIMTDSA-N 2-[bis(2-hydroxyethyl)amino]ethanol;(2s)-2-[dodecanoyl(methyl)amino]propanoic acid Chemical compound OCCN(CCO)CCO.CCCCCCCCCCCC(=O)N(C)[C@@H](C)C(O)=O GRYDXAUFDMVZNZ-UQKRIMTDSA-N 0.000 description 1
- UNSAJINGUOTTRA-UHFFFAOYSA-N 3-(3-bromophenyl)prop-2-yn-1-ol Chemical compound OCC#CC1=CC=CC(Br)=C1 UNSAJINGUOTTRA-UHFFFAOYSA-N 0.000 description 1
- VBOZFTYRQDFTKX-UHFFFAOYSA-N 3-methylbutane-1,1-diol Chemical compound CC(C)CC(O)O VBOZFTYRQDFTKX-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- 241000009881 Aega Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- DSLZVSRJTYRBFB-LLEIAEIESA-N D-glucaric acid Chemical compound OC(=O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O DSLZVSRJTYRBFB-LLEIAEIESA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 235000009161 Espostoa lanata Nutrition 0.000 description 1
- 240000001624 Espostoa lanata Species 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- 150000000994 L-ascorbates Chemical class 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KVTFEOAKFFQCCX-UHFFFAOYSA-M N-hexadecanoylglycinate Chemical compound CCCCCCCCCCCCCCCC(=O)NCC([O-])=O KVTFEOAKFFQCCX-UHFFFAOYSA-M 0.000 description 1
- GNMAJAFGCGXYGH-ZOWNYOTGSA-M N[C@@H](CCC(=O)[O-])C(=O)OC(CCCCCCCCC=C)=O.[Na+] Chemical compound N[C@@H](CCC(=O)[O-])C(=O)OC(CCCCCCCCC=C)=O.[Na+] GNMAJAFGCGXYGH-ZOWNYOTGSA-M 0.000 description 1
- ACAXXPXMEBRGLB-IZHYLRJQSA-L N[C@@H](CCC(=O)[O-])C(=O)OC(CCCCCCCCC=C)=O.[Na+].[Na+].C(CCCCCCCCC=C)(=O)OC([C@@H](N)CCC(=O)[O-])=O Chemical compound N[C@@H](CCC(=O)[O-])C(=O)OC(CCCCCCCCC=C)=O.[Na+].[Na+].C(CCCCCCCCC=C)(=O)OC([C@@H](N)CCC(=O)[O-])=O ACAXXPXMEBRGLB-IZHYLRJQSA-L 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- 238000003436 Schotten-Baumann reaction Methods 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- FMRLDPWIRHBCCC-UHFFFAOYSA-L Zinc carbonate Chemical compound [Zn+2].[O-]C([O-])=O FMRLDPWIRHBCCC-UHFFFAOYSA-L 0.000 description 1
- CANRESZKMUPMAE-UHFFFAOYSA-L Zinc lactate Chemical compound [Zn+2].CC(O)C([O-])=O.CC(O)C([O-])=O CANRESZKMUPMAE-UHFFFAOYSA-L 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 150000001266 acyl halides Chemical class 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- QNAYBMKLOCPYGJ-UHFFFAOYSA-M alaninate Chemical compound CC(N)C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-M 0.000 description 1
- 150000001294 alanine derivatives Chemical class 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- OCSIXPGPUXCISD-UHFFFAOYSA-N azane;2-[dodecanoyl(methyl)amino]acetic acid Chemical compound N.CCCCCCCCCCCC(=O)N(C)CC(O)=O OCSIXPGPUXCISD-UHFFFAOYSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 150000001649 bromium compounds Chemical class 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- NKWPZUCBCARRDP-UHFFFAOYSA-L calcium bicarbonate Chemical compound [Ca+2].OC([O-])=O.OC([O-])=O NKWPZUCBCARRDP-UHFFFAOYSA-L 0.000 description 1
- 229910000020 calcium bicarbonate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- KEOZCAIGSRBLGC-UHFFFAOYSA-L calcium;2-oxopyrrolidine-1-carboxylate Chemical compound [Ca+2].[O-]C(=O)N1CCCC1=O.[O-]C(=O)N1CCCC1=O KEOZCAIGSRBLGC-UHFFFAOYSA-L 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- MRUAUOIMASANKQ-UHFFFAOYSA-O carboxymethyl-[3-(dodecanoylamino)propyl]-dimethylazanium Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC(O)=O MRUAUOIMASANKQ-UHFFFAOYSA-O 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 229940073507 cocamidopropyl betaine Drugs 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 229940065856 cocoyl glycinate Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- OGAOAWXZOWXVOG-UHFFFAOYSA-L copper;2-oxopyrrolidine-1-carboxylate Chemical compound [Cu+2].[O-]C(=O)N1CCCC1=O.[O-]C(=O)N1CCCC1=O OGAOAWXZOWXVOG-UHFFFAOYSA-L 0.000 description 1
- IPIVAXLHTVNRBS-UHFFFAOYSA-N decanoyl chloride Chemical compound CCCCCCCCCC(Cl)=O IPIVAXLHTVNRBS-UHFFFAOYSA-N 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- BFBKGNFWEGCGSD-XFMZQWNHSA-L dipotassium (4S)-4-amino-5-octanoyloxy-5-oxopentanoate Chemical compound [K+].[K+].CCCCCCCC(=O)OC(=O)[C@@H](N)CCC([O-])=O.CCCCCCCC(=O)OC(=O)[C@@H](N)CCC([O-])=O BFBKGNFWEGCGSD-XFMZQWNHSA-L 0.000 description 1
- JOLYVEWZEPKDIJ-UTLKBRERSA-L dipotassium;(2s)-2-(dodecanoylamino)pentanedioate Chemical compound [K+].[K+].CCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC([O-])=O JOLYVEWZEPKDIJ-UTLKBRERSA-L 0.000 description 1
- ACNAFCGCINVEDL-GXKRWWSZSA-L dipotassium;(2s)-2-(undec-10-enoylamino)pentanedioate Chemical compound [K+].[K+].[O-]C(=O)CC[C@@H](C([O-])=O)NC(=O)CCCCCCCCC=C ACNAFCGCINVEDL-GXKRWWSZSA-L 0.000 description 1
- NGGLRFLSFZIKLE-XFMZQWNHSA-L disodium (4S)-4-amino-5-octanoyloxy-5-oxopentanoate Chemical compound [Na+].[Na+].CCCCCCCC(=O)OC(=O)[C@@H](N)CCC([O-])=O.CCCCCCCC(=O)OC(=O)[C@@H](N)CCC([O-])=O NGGLRFLSFZIKLE-XFMZQWNHSA-L 0.000 description 1
- 229940079784 disodium stearoyl glutamate Drugs 0.000 description 1
- WODOUQLMOIMKAL-FJSYBICCSA-L disodium;(2s)-2-(octadecanoylamino)pentanedioate Chemical compound [Na+].[Na+].CCCCCCCCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC([O-])=O WODOUQLMOIMKAL-FJSYBICCSA-L 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229910001651 emery Inorganic materials 0.000 description 1
- MFGZXPGKKJMZIY-UHFFFAOYSA-N ethyl 5-amino-1-(4-sulfamoylphenyl)pyrazole-4-carboxylate Chemical compound NC1=C(C(=O)OCC)C=NN1C1=CC=C(S(N)(=O)=O)C=C1 MFGZXPGKKJMZIY-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 150000004675 formic acid derivatives Chemical class 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-L fumarate(2-) Chemical class [O-]C(=O)\C=C\C([O-])=O VZCYOOQTPOCHFL-OWOJBTEDSA-L 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 229940049906 glutamate Drugs 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 125000001487 glyoxylate group Chemical class O=C([O-])C(=O)[*] 0.000 description 1
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 150000004694 iodide salts Chemical class 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 150000003893 lactate salts Chemical class 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940075468 lauramidopropyl betaine Drugs 0.000 description 1
- 229940071145 lauroyl sarcosinate Drugs 0.000 description 1
- 229940094506 lauryl betaine Drugs 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- QWDJLDTYWNBUKE-UHFFFAOYSA-L magnesium bicarbonate Chemical compound [Mg+2].OC([O-])=O.OC([O-])=O QWDJLDTYWNBUKE-UHFFFAOYSA-L 0.000 description 1
- 239000002370 magnesium bicarbonate Substances 0.000 description 1
- 229910000022 magnesium bicarbonate Inorganic materials 0.000 description 1
- 235000014824 magnesium bicarbonate Nutrition 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 235000011147 magnesium chloride Nutrition 0.000 description 1
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 1
- 239000004137 magnesium phosphate Substances 0.000 description 1
- 229960002261 magnesium phosphate Drugs 0.000 description 1
- 229910000157 magnesium phosphate Inorganic materials 0.000 description 1
- 235000010994 magnesium phosphates Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 150000002688 maleic acid derivatives Chemical class 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 150000004701 malic acid derivatives Chemical class 0.000 description 1
- 150000002690 malonic acid derivatives Chemical class 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- DVEKCXOJTLDBFE-UHFFFAOYSA-N n-dodecyl-n,n-dimethylglycinate Chemical compound CCCCCCCCCCCC[N+](C)(C)CC([O-])=O DVEKCXOJTLDBFE-UHFFFAOYSA-N 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- MLQBTMWHIOYKKC-UHFFFAOYSA-N octadec-9-enoyl chloride Chemical compound CCCCCCCCC=CCCCCCCCC(Cl)=O MLQBTMWHIOYKKC-UHFFFAOYSA-N 0.000 description 1
- OEIJHBUUFURJLI-UHFFFAOYSA-N octane-1,8-diol Chemical compound OCCCCCCCCO OEIJHBUUFURJLI-UHFFFAOYSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 150000003891 oxalate salts Chemical class 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 108700009886 palmitoyl sarcosine Proteins 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 229940044654 phenolsulfonic acid Drugs 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 229940082006 potassium cocoyl glutamate Drugs 0.000 description 1
- 229940099874 potassium lauroyl glutamate Drugs 0.000 description 1
- RJLXQRRDQRGFJR-ZOWNYOTGSA-M potassium;(2s)-5-hydroxy-5-oxo-2-(undec-10-enoylamino)pentanoate Chemical compound [K+].OC(=O)CC[C@@H](C([O-])=O)NC(=O)CCCCCCCCC=C RJLXQRRDQRGFJR-ZOWNYOTGSA-M 0.000 description 1
- CHTYKHAFYAUJHL-PPHPATTJSA-M potassium;(4s)-4-amino-5-octanoyloxy-5-oxopentanoate Chemical compound [K+].CCCCCCCC(=O)OC(=O)[C@@H](N)CCC([O-])=O CHTYKHAFYAUJHL-PPHPATTJSA-M 0.000 description 1
- KCQOKZAQSWTPIL-BDQAORGHSA-M potassium;(4s)-5-hydroxy-4-(octadecanoylamino)-5-oxopentanoate Chemical compound [H+].[K+].CCCCCCCCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC([O-])=O KCQOKZAQSWTPIL-BDQAORGHSA-M 0.000 description 1
- KYLDDUZJZSKJER-NTISSMGPSA-M potassium;(4s)-5-hydroxy-5-oxo-4-(tetradecanoylamino)pentanoate Chemical compound [H+].[K+].CCCCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC([O-])=O KYLDDUZJZSKJER-NTISSMGPSA-M 0.000 description 1
- WLPORNKIACJZBO-UHFFFAOYSA-M potassium;2-(dodecanoylamino)acetate Chemical compound [K+].CCCCCCCCCCCC(=O)NCC([O-])=O WLPORNKIACJZBO-UHFFFAOYSA-M 0.000 description 1
- JEMLSRUODAIULV-UHFFFAOYSA-M potassium;2-[dodecanoyl(methyl)amino]acetate Chemical compound [K+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O JEMLSRUODAIULV-UHFFFAOYSA-M 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
- DQAKJEWZWDQURW-UHFFFAOYSA-N pyrrolidonecarboxylic acid Chemical class OC(=O)N1CCCC1=O DQAKJEWZWDQURW-UHFFFAOYSA-N 0.000 description 1
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 150000003873 salicylate salts Chemical class 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229940043230 sarcosine Drugs 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229940078455 sodium lauroyl aspartate Drugs 0.000 description 1
- 229940077092 sodium myristoyl glutamate Drugs 0.000 description 1
- 229940060304 sodium myristoyl sarcosinate Drugs 0.000 description 1
- 229940077089 sodium palmitoyl glutamate Drugs 0.000 description 1
- FCBUGCHAVCFTHW-NTISSMGPSA-N sodium;(2s)-2-(tetradecanoylamino)pentanedioic acid Chemical compound [Na].CCCCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC(O)=O FCBUGCHAVCFTHW-NTISSMGPSA-N 0.000 description 1
- IEXXLSKKBWIDAC-ZOWNYOTGSA-M sodium;(3s)-3-(dodecanoylamino)-4-hydroxy-4-oxobutanoate Chemical compound [Na+].CCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CC(O)=O IEXXLSKKBWIDAC-ZOWNYOTGSA-M 0.000 description 1
- IFYJQGOKVNCMTC-RSAXXLAASA-M sodium;(3s)-4-hydroxy-4-oxo-3-(tetradecanoylamino)butanoate Chemical compound [H+].[Na+].CCCCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CC([O-])=O IFYJQGOKVNCMTC-RSAXXLAASA-M 0.000 description 1
- KLIFRVSZGDONER-FERBBOLQSA-M sodium;(4s)-4-(hexadecanoylamino)-5-hydroxy-5-oxopentanoate Chemical compound [H+].[Na+].CCCCCCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC([O-])=O KLIFRVSZGDONER-FERBBOLQSA-M 0.000 description 1
- KPTLOKOTBGOYCE-PPHPATTJSA-M sodium;(4s)-4-amino-5-octanoyloxy-5-oxopentanoate Chemical compound [Na+].CCCCCCCC(=O)OC(=O)[C@@H](N)CCC([O-])=O KPTLOKOTBGOYCE-PPHPATTJSA-M 0.000 description 1
- YBDZITJALUSANZ-UHFFFAOYSA-M sodium;2-(tetradecanoylamino)acetate Chemical compound [Na+].CCCCCCCCCCCCCC(=O)NCC([O-])=O YBDZITJALUSANZ-UHFFFAOYSA-M 0.000 description 1
- KHCOJQDJOCNUGV-UHFFFAOYSA-M sodium;2-[methyl(tetradecanoyl)amino]acetate Chemical compound [Na+].CCCCCCCCCCCCCC(=O)N(C)CC([O-])=O KHCOJQDJOCNUGV-UHFFFAOYSA-M 0.000 description 1
- VLKIFCBXANYYCK-GMFCBQQYSA-M sodium;2-[methyl-[(z)-octadec-9-enoyl]amino]acetate Chemical compound [Na+].CCCCCCCC\C=C/CCCCCCCC(=O)N(C)CC([O-])=O VLKIFCBXANYYCK-GMFCBQQYSA-M 0.000 description 1
- ISONEALTCIBOKV-UHFFFAOYSA-M sodium;3-[methyl(tetradecanoyl)amino]propanoate Chemical compound [Na+].CCCCCCCCCCCCCC(=O)N(C)CCC([O-])=O ISONEALTCIBOKV-UHFFFAOYSA-M 0.000 description 1
- 150000003890 succinate salts Chemical class 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 150000003892 tartrate salts Chemical class 0.000 description 1
- LPWCRLGKYWVLHQ-UHFFFAOYSA-N tetradecanoyl chloride Chemical compound CCCCCCCCCCCCCC(Cl)=O LPWCRLGKYWVLHQ-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- HFRXJVQOXRXOPP-UHFFFAOYSA-N thionyl bromide Chemical compound BrS(Br)=O HFRXJVQOXRXOPP-UHFFFAOYSA-N 0.000 description 1
- LSJNBGSOIVSBBR-UHFFFAOYSA-N thionyl fluoride Chemical compound FS(F)=O LSJNBGSOIVSBBR-UHFFFAOYSA-N 0.000 description 1
- RKIDPTUGNXTOMU-UHFFFAOYSA-N thionyl iodide Chemical compound IS(I)=O RKIDPTUGNXTOMU-UHFFFAOYSA-N 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 150000003627 tricarboxylic acid derivatives Chemical class 0.000 description 1
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229940056904 zinc ascorbate Drugs 0.000 description 1
- 239000011667 zinc carbonate Substances 0.000 description 1
- 235000004416 zinc carbonate Nutrition 0.000 description 1
- 229910000010 zinc carbonate Inorganic materials 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- 239000011746 zinc citrate Substances 0.000 description 1
- 235000006076 zinc citrate Nutrition 0.000 description 1
- 229940068475 zinc citrate Drugs 0.000 description 1
- 239000011576 zinc lactate Substances 0.000 description 1
- 235000000193 zinc lactate Nutrition 0.000 description 1
- 229940050168 zinc lactate Drugs 0.000 description 1
- 229940118827 zinc phenolsulfonate Drugs 0.000 description 1
- LRXTYHSAJDENHV-UHFFFAOYSA-H zinc phosphate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O LRXTYHSAJDENHV-UHFFFAOYSA-H 0.000 description 1
- 229910000165 zinc phosphate Inorganic materials 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- WWRJFSIRMWUMAE-ZZMNMWMASA-L zinc;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3-hydroxy-5-oxo-2h-furan-4-olate Chemical compound [Zn+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] WWRJFSIRMWUMAE-ZZMNMWMASA-L 0.000 description 1
- BOVNWDGXGNVNQD-UHFFFAOYSA-L zinc;2-hydroxybenzenesulfonate Chemical compound [Zn+2].OC1=CC=CC=C1S([O-])(=O)=O.OC1=CC=CC=C1S([O-])(=O)=O BOVNWDGXGNVNQD-UHFFFAOYSA-L 0.000 description 1
- PCHQDTOLHOFHHK-UHFFFAOYSA-L zinc;hydrogen carbonate Chemical compound [Zn+2].OC([O-])=O.OC([O-])=O PCHQDTOLHOFHHK-UHFFFAOYSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/342—Alcohols having more than seven atoms in an unbroken chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/14—Preparations for removing make-up
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
本发明涉及用于清洁角蛋白材料和/或从角蛋白材料卸妆的组合物,该组合物在水相中包含:a)至少一种氨基酸表面活性剂;b)至少一种C12‑C24饱和一元醇;和c)至少一种二价金属盐和/或三价金属盐。本发明还涉及用于清洁角蛋白材料(尤其是皮肤或头发)和/或从角蛋白材料(尤其是皮肤或头发)卸妆的非治疗性方法,该方法包括将该组合物施用到角蛋白材料(尤其是皮肤或头发),以及在任选的时间段后洗去所述组合物。
Description
技术领域
本发明涉及化妆品组合物,尤其是用于清洁角蛋白材料和/或从角蛋白材料卸妆的组合物。本发明还涉及使用所述组合物的用于清洁角蛋白材料和/或从角蛋白材料卸妆的非治疗性方法。
背景技术
清洁皮肤或从皮肤卸妆对于护理皮肤十分重要。其必须尽可能有效,因为油腻的残余物在皮肤褶皱中累积,并且可堵塞皮肤的毛孔并导致斑点的出现,所述油腻的残余物例如过量的皮脂、日常使用的化妆产品和彩妆产品(尤其是防水产品)的残留物。
已知若干类型的皮肤清洁或卸妆产品,例如可冲洗的无水油和凝胶、发泡霜(foaming creams)和乳液。
可冲洗的无水油和凝胶凭借存在于这些配制物中的油而具有清洁或卸妆作用。这些油使得可以溶解脂肪残余物和分散彩妆颜料。这些产品有效且耐受良好。
然而,它们表现出厚重、不发泡和在施用时不赋予好的皮肤妆效(skin finish)的缺点,这从化妆品的角度来看是不利的。
另一方面,发泡霜、乳液和凝胶凭借表面活性剂而具有清洁或卸妆作用,所述表面活性剂使脂肪残余物悬浮在面部上。它们有效并且使用起来愉悦,因为它们发泡并且易于除去。
另外,对于一些乳液而言,存在归因于低粘度的滴落问题。
氨基酸表面活性剂由于其温和性而常用于皮肤清洁或卸妆产品中。然而,可冲洗性并不令人满意。
此外,对于一些商业清洁剂,洗去速度不快,这造成不愉快的使用。
因此,对配制用于清洁角蛋白材料或从角蛋白材料卸妆的组合物存在需求,该组合物是温和且耐油的,没有滴落问题,可提供好的泡沫密度、快的洗去速度和好的皮肤妆效(即不紧绷不干燥的皮肤感觉)。
发明概述
发明人已发现,可通过本发明来实现这样的需求。
因此,根据一个方面,本发明提供用于清洁角蛋白材料和/或从角蛋白材料卸妆的组合物,该组合物在水相中包含:
a)至少一种氨基酸表面活性剂;
b)至少一种C12-C24饱和一元醇;和
c)至少一种二价金属盐和/或三价金属盐。
根据本发明的组合物呈现糊状物、霜或凝胶质地的乳液特征。
根据本发明的组合物是温和且耐油的,并且没有滴落问题。
根据本发明的组合物在施用后可提供好的泡沫密度、快的洗去速度和好的皮肤妆效(即不紧绷且不干燥的皮肤感觉)。
其可以用作日常的洁面剂、卸妆剂或洗发剂。本发明组合物是洗去型产品。因此,可将此类组合物施用在皮肤(即面部和/或身体)或头发上,并且然后用冲洗水冲洗。
根据另一个方面,本发明提供用于清洁角蛋白材料(尤其是皮肤或头发)和/或从角蛋白材料(尤其是皮肤或头发)卸妆的非治疗性方法,该方法包括将根据本发明的组合物施用到角蛋白材料(尤其是皮肤或头发),以及在任选的时间段后洗去所述组合物。
在阅读以下描述和实施例后,本发明的其它主题和特性、方面和优点将甚至更清楚地显现。
发明详述
除非另外定义,否则本文使用的所有技术和科学术语具有与本发明所属领域的技术人员所通常理解的相同的含义。当术语在本说明书中的定义与本发明所属领域的技术人员所通常理解的含义冲突时,应适用本文所描述的定义。
在以下内容中,且除非另外指明,否则值的范围的界限包含在该范围内,在表述“介于…和…之间”和“…至…”中尤其如此。
此外,本说明书中使用的表述“至少一个/种”等同于表述“一个/种或多个/种”。
在本申请通篇中,术语“包含/包括”应解释为涵盖所有具体提及的特征以及任选的、另外的、未指明的那些。如本文所用,术语“包含/包括”的使用还公开了其中不存在除具体提及的特征之外的特征(即(即“由…组成”)的实施方案。
除非另外指明,否则说明书和权利要求书中使用的表示成分的量等等的所有数值应理解为被术语“约”修饰。因此,除非相反地指出,否则本文描述的数值和参数是能够根据所需目的视需要变化的近似值。
出于本发明的目的,术语“角蛋白材料”意在涵盖人的皮肤、粘膜(例如嘴唇)和头发。根据本发明最特别考虑面部皮肤和头发。
除非另外指明,否则本发明中的所有百分比指重量百分比。
根据一个方面,本发明涉及用于清洁角蛋白材料和/或从角蛋白材料卸妆的组合物,该组合物在水相中包含:
a)至少一种氨基酸表面活性剂;
b)至少一种C12-C24饱和一元醇;和
c)至少一种二价金属盐和/或三价金属盐。
氨基酸表面活性剂
根据本发明的组合物包含至少一种氨基酸表面活性剂。
在一个实施方案中,所述氨基酸表面活性剂衍生自氨基酸的羧酸盐,其中用C8-C22脂肪酸衍生物将位于氨基酸盐的α碳或β碳上的氨基酰化。
可以通过常规方式,例如通过用碱中和相应的氨基酸来形成这些氨基酸的羧酸盐。在碱的存在下,经由公知的肖顿-鲍曼(Schotten-Baumann)反应,用脂肪酸卤化物(酰卤)将位于被中和的氨基酸的α碳或β碳上的氨基酰化,得到酰胺,从而形成所需的表面活性剂反应产物,即氨基酸表面活性剂。用于氨基酸羧酸盐的酰化的合适的酰卤包括酰氯、酰溴、酰氟和酰碘。可以通过使饱和或不饱和的直链或支链C8-C22脂肪酸与亚硫酰卤(亚硫酰溴、亚硫酰氯、亚硫酰氟和亚硫酰碘)反应来制备酰卤。代表性酰卤包括但不限于选自以下各项的酰氯:癸酰氯、十二烷酰氯(月桂酰氯)、椰油酰氯(椰子油衍生的脂肪酸氯化物)、十四烷酰氯(肉豆蔻酰氯)、十六烷酰氯(棕榈酰氯)、十八烷酰氯(硬脂酰氯)、9-十八碳烯酰氯(油酰氯)、二十烷酰氯(花生酰氯)、二十二烷酰氯(山萮酰氯)、及其任何混合物。其它的酰卤包括前述脂肪酸的溴化物、氟化物和碘化物。用于制备酰卤的方法以及用于酰化氨基酸的替代性方法阐述于2008年8月21日公布的美国专利申请公布第2008/0200704号中,通过引用将所述申请并入本文。
优选地,所述氨基酸表面活性剂由式(I)代表:
其中:
Z代表具有8至22个碳原子的饱和或不饱和的直链或支链烃基,
X是氢或甲基,
n是0或1,
Y选自氢、-CH3、-CH(CH3)2、-CH2CH(CH3)2、-CH(CH3)CH2CH3、-CH2C6H5、-CH2C2H4OH、-CH2OH、-CH(OH)CH3、-(CH2)4NH2、-(CH2)3NHC(NH)NH2、-CH2C(O)O-M+、-(CH2)2C(O)OH、-(CH2)2C(O)O-M+,且
M是其中COO为抗衡阴离子的成盐阳离子,例如钠、钾、铵或三乙醇胺。
在一个实施方案中,在式(I)中:
Z代表饱和或不饱和的直链或支链C8-C22烷基,
X是氢或甲基,
n是0,
Y选自氢、-(CH2)2C(O)OH、-(CH2)2C(O)O-M+,且
M是其中COO为抗衡阴离子的成盐阳离子,例如钠、钾、铵或三乙醇胺。
根据本发明的一个优选实施方案,在式(I)中:
Z代表饱和或不饱和的直链或支链C8-C22烷基,
X是氢或甲基,
n是0,
Y选自氢、-(CH2)2C(O)OH、-(CH2)2C(O)O-M+,且
M是其中COO为抗衡阴离子的成盐阳离子,例如钠、钾、铵或三乙醇胺。
氨基酸表面活性剂的实例是以下各项的盐及其任何混合物:丙氨酸、精氨酸、天冬氨酸、谷氨酸、甘氨酸、异亮氨酸、亮氨酸、赖氨酸、苯丙氨酸、丝氨酸、酪氨酸、缬氨酸、肌氨酸。更具体地,可提及氨基酸表面活性剂,例如辛酰谷氨酸二钾、十一碳烯酰谷氨酸二钾、辛酰谷氨酸二钠、椰油酰谷氨酸二钠、月桂酰谷氨酸二钠、硬脂酰谷氨酸二钠、十一碳烯酰谷氨酸二钠、辛酰谷氨酸钾、椰油酰谷氨酸钾、月桂酰谷氨酸钾、肉豆蔻酰谷氨酸钾、硬脂酰谷氨酸钾、十一碳烯酰谷氨酸钾、辛酰谷氨酸钠、椰油酰谷氨酸钠、月桂酰谷氨酸钠、肉豆蔻酰谷氨酸钠、橄榄酰谷氨酸钠、棕榈酰谷氨酸钠、硬脂酰谷氨酸钠、十一碳烯酰谷氨酸钠、椰油酰甲基β-丙氨酸盐、月桂酰β-丙氨酸盐、月桂酰甲基β-丙氨酸盐、肉豆蔻酰β-丙氨酸盐、月桂酰甲基β-丙氨酸钾、椰油酰丙氨酸钠、椰油酰甲基β-丙氨酸钠和肉豆蔻酰甲基β-丙氨酸钠、棕榈酰甘氨酸盐、月桂酰甘氨酸钠、椰油酰甘氨酸钠、肉豆蔻酰甘氨酸钠、月桂酰甘氨酸钾、椰油酰甘氨酸钾、月桂酰肌氨酸钾、椰油酰肌氨酸钾、椰油酰肌氨酸钠、月桂酰肌氨酸钠、肉豆蔻酰肌氨酸钠、油酰肌氨酸钠、棕榈酰肌氨酸钠、月桂酰肌氨酸铵、月桂酰天冬氨酸钠、肉豆蔻酰天冬氨酸钠、椰油酰天冬氨酸钠、己酰天冬氨酸钠、月桂酰天冬氨酸二钠、肉豆蔻酰天冬氨酸二钠、椰油酰天冬氨酸二钠、己酰天冬氨酸二钠、月桂酰天冬氨酸钾、肉豆蔻酰天冬氨酸钾、椰油酰天冬氨酸钾、己酰天冬氨酸钾、月桂酰天冬氨酸二钾、肉豆蔻酰天冬氨酸二钾、椰油酰天冬氨酸二钾、己酰天冬氨酸二钾、及其混合物。
可以提及市售可得的氨基酸表面活性剂,例如酰基肌氨酸盐,例如由Ciba公司以名称Sarkosyl NL销售的月桂酰肌氨酸钠或由SEPPIC公司以名称Oramix L/>销售的月桂酰肌氨酸钠、由Nikkol公司以名称Nikkol Sarcosinate/>销售的肉豆蔻酰肌氨酸钠、或由Nikkol公司以名称Nikkol Sarcosinate/>销售的棕榈酰肌氨酸钠;丙氨酸盐,例如由Nikkol公司以名称Sodium Nikkol Alaninate LN/>销售的N-月桂酰基-N-甲基酰胺基丙酸钠或由Kawaken公司以名称Alanone/>销售的N-月桂酰基-N-甲基酰胺基丙酸钠、以及由Kawaken公司以名称Alanone/>销售的N-月桂酰基-N-甲基丙氨酸三乙醇胺;N-酰基谷氨酸盐,例如由Ajinomoto公司以名称Acylglutamate/>销售的单椰油酰谷氨酸三乙醇胺和由Ajinomoto公司以名称Acylglutamate/>销售的月桂酰谷氨酸三乙醇胺;甘氨酸盐,例如由Ajinomoto公司以名称Amilite/>销售的N-椰油酰甘氨酸钠;天冬氨酸盐,例如由Mitsubishi公司以名称/>销售的N-月桂酰天冬氨酸三乙醇胺与N-肉豆蔻酰天冬氨酸三乙醇胺的混合物;柠檬酸盐;及其任何混合物。
根据本发明,优选的氨基酸表面活性剂选自月桂酰肌氨酸钠、椰油酰甘氨酸钠、椰油酰谷氨酸钠、硬脂酰谷氨酸钠、椰油酰谷氨酸二钠、月桂酰谷氨酸钠、椰油酰甘氨酸钾、椰油酰谷氨酸三乙醇胺、或其混合物。
可提及在市售可得的组合物中的优选氨基酸表面活性剂月桂酰肌氨酸钠(由Seppic销售的ORAMIX L 30)、椰油酰甘氨酸钠(和)水(由Ajinomoto销售的GCS-12K)、椰油酰谷氨酸钠(和)椰油酰谷氨酸二钠(由Ajinomoto销售的/>CS-22)、以及月桂酰谷氨酸钠(由Ajinomoto销售的/>LS-11)。
根据一个优选实施方案,氨基酸表面活性剂选自月桂酰肌氨酸钠、椰油酰甘氨酸钠、椰油酰谷氨酸钠、硬脂酰谷氨酸钠、椰油酰谷氨酸二钠、月桂酰谷氨酸钠、椰油酰甘氨酸钾、椰油酰谷氨酸三乙醇胺、及其混合物。
由于使用氨基酸表面活性剂,因此根据本发明的组合物不对角蛋白材料产生刺激。
有利地,相对于根据本发明的组合物的总重量计,氨基酸表面活性剂以3wt.%至50wt.%,优选5wt.%至30wt.%,更优选10wt.%至20wt.%的量存在于该组合物中。
C12-C24饱和一元醇
根据第一方面,根据本发明的组合物包含至少一种C12-C24饱和一元醇。
C12-C24饱和一元醇具有结构R-OH,其中R表示包含12至24个碳原子的烷基。
优选地,一元醇包含12至22个碳原子。
优选地,适合在本发明中使用的C12-C24饱和一元醇选自鲸蜡醇、硬脂醇、鲸蜡硬脂醇、肉豆蔻醇、月桂醇、十三烷醇、十五烷醇、十六烷醇、花生醇和山萮醇;它们优选选自月桂醇、山萮醇、鲸蜡醇、硬脂醇和鲸蜡硬脂醇。
作为可以是最尤其适合在本发明中使用的油醇,可使用例如由BASF公司以名称HDOCENOL 80/85 V/MB销售的产品或由CRODA公司以名CRODACOL A 10销售的产品。
作为可以是最尤其适合在本发明中使用的鲸蜡醇,可使用例如由EcogreenOleochemicals公司以名称16/98 F和/>16/98 P销售的产品、由EvonikGoldschmidt公司以名称/>16销售的产品、由Cognis公司以名称/>16销售的产品、由VVF公司以名称/>1698销售的产品、由Oxiteno公司以名称1698 P销售的产品、由Emery Oleochemicals公司以名称Cetyl Alcohol 98%Min销售的产品、由Godrej Industries公司以名称/>16(98%)销售的产品、由Sasol公司以名称/>16-98销售的产品、由Kao公司以名称/>6098销售的产品以及由Aegis Chemical公司以名称/>16销售的产品。
作为最尤其适合在本发明中使用的硬脂醇,可使用例如由Evonik Goldschmidt公司以名称18销售的那些、由Ecogreen Oleochemicals公司以名称18/98F和/>18/98P销售的那些、由Cognis公司以名称/>18销售的那些、由Kao公司以名称/>8098销售的那些、由Aegis Chemical公司以名称18销售的那些、由Sasol公司以名称/>18-98销售的那些以及由NihonYushi公司以名称/>45销售的那些。
作为最尤其适合在本发明中使用的鲸蜡硬脂醇,可使用例如由EcogreenOleochemicals公司以名称68/50 F和/>68/50 P销售的那些、由Cognis公司以名称/>O OR和/>O OR Flakes销售的那些、由Oxiteno公司以名称1618 C50 P销售的那些、由Sasol公司以名称/>16-18 EN销售的那些、由Industria Quimica Del Centro公司以名称Alcohol Cetoestearilico 50/50销售的那些、由New Japan Chemical公司以名称/>30 CK销售的那些、由Evonik Goldschmidt公司以名称Cetylstearyl Alcohol 50:50销售的那些、由Kao公司以名称/>6850销售的那些、由VVF公司以名称/>1618(50:50)销售的那些以及由GodrejIndustries公司以名称/>1618 50:50 OR销售的那些。
作为可以是最尤其适合在本发明中使用的山萮醇,可使用例如由BASF公司以名称LANETTE 22销售的产品、由VVF公司以名称VEGAROL 2270销售的产品以及由SASOL公司以名称NAFOL 1822 C销售的产品。
有利地,相对于组合物的总重量计,C12-C24饱和一元醇以0.3wt.%至10wt.%,优选0.5wt.%至8wt.%,更优选0.8wt.%至5wt.%的量存在于该组合物中。
金属盐
根据本发明的组合物包含至少一种二价金属盐和/或三价金属盐。
二价金属盐和/或三价金属盐包括金属离子M1n+。优选地,M1n+选自Mg2+、Ca2+、Zn2+、Fe2+、Mn2+、Cu2+、Al3+和Fe3+。
金属盐选自有机酸或无机酸的金属盐。
作为有机酸的实例,可提及抗坏血酸、甲酸、乙酸、乙醇酸、葡糖酸、乳酸、扁桃酸、草酸、马来酸、丙二酸、乙醛酸、琥珀酸、己二酸、富马酸、癸二酸、柠檬酸、酒石酸、苹果酸、三羧酸、戊二酸、葡糖二酸、吡咯烷酮羧酸、苯酚磺酸、水杨酸等。
作为无机酸的实例,可提及硫酸、碳酸、硅酸、盐酸、硝酸、磷酸等。
优选地,无机酸的金属盐选自金属的氯化物、硫酸盐、硝酸盐、碳酸盐和碳酸氢盐、磷酸盐、硅酸盐,及其混合物,其中金属选自Mg、Ca、Zn、Mn、Cu、Al和Fe。
更优选地,无机酸的金属盐选自氯化钙、硫酸钙、硝酸钙、碳酸钙和碳酸氢钙、磷酸钙、氯化锌、硫酸锌、硝酸锌、碳酸锌和碳酸氢锌、磷酸锌、氯化镁、硫酸镁、硝酸镁、碳酸镁和碳酸氢镁、磷酸镁、硅酸镁铝、硅酸铝钙钠、及其混合物。
优选地,有机酸的金属盐选自金属的抗坏血酸盐、甲酸盐、乙酸盐、乙醇酸盐、葡糖酸盐、乳酸盐、扁桃酸盐、草酸盐、马来酸盐、丙二酸盐、乙醛酸盐、琥珀酸盐、己二酸盐、富马酸盐、癸二酸盐、柠檬酸盐、酒石酸盐、苹果酸盐、三羧酸盐、戊二酸盐、葡糖二酸盐、吡咯烷酮羧酸盐、苯酚磺酸盐、水杨酸盐,及其混合物,其中金属选自Mg、Ca、Zn、Mn、Cu、Al和Fe。
更优选地,有机酸的金属盐选自葡糖酸镁、PCA镁(吡咯烷酮羧酸镁)、乙酸镁、PCA钙(吡咯烷酮羧酸钙)、乳酸锌、葡糖酸锌、苯酚磺酸锌、水杨酸锌、PCA锌(吡咯烷酮羧酸锌)、柠檬酸锌、抗坏血酸锌、PCA铜(吡咯烷酮羧酸铜)、葡糖酸铜、及其混合物。
根据一个优选实施方案,金属盐选自葡糖酸镁、PCA镁、硫酸镁、乙酸镁、碳酸镁、硅酸镁铝、碳酸钙、PCA钙、硅酸铝钙钠、氯化钙、碳酸钙、PCA锌、葡糖酸锌、PCA铜、葡糖酸铜、及其混合物。
有利地,相对于根据本发明的组合物的总重量计,金属盐以0.25wt.%至10wt.%,优选0.25wt.%至5wt.%,更优选0.5wt.%至3wt.%的量存在于该组合物中。
两性表面活性剂
优选地,根据本发明的组合物进一步包含至少一种两性表面活性剂,其选自甜菜碱、(C8-C20)烷基甜菜碱、(C8-C20)烷基酰胺基(C1-C6)烷基甜菜碱、及其混合物。
作为甜菜碱,可尤其提及(C8-C20)烷基甜菜碱,例如椰油基甜菜碱,例如由Cognis公司以名称Dehyton销售的产品;月桂基甜菜碱,例如由Clariant公司以名称Genagen/>销售的产品。
在(C8-C20)烷基酰胺基(C1-C6)烷基甜菜碱之中,可提及例如椰油酰胺基丙基甜菜碱,其由Sanyo公司以名称Lebon 2000销售或由Albright&Wilson公司以名称Empigen/>销售;或月桂酰胺基丙基甜菜碱,其由Witco公司以名称Rewoteric销售。
优选地,两性表面活性剂选自(C8-C20)烷基酰胺基(C1-C6)烷基甜菜碱,且更优选选自(C12-C20)烷基酰胺基(C1-C6)烷基甜菜碱。最优选地,两性表面活性剂是椰油酰胺基丙基甜菜碱。
有利地,相对于根据本发明的组合物的总重量计,两性表面活性剂以0.5wt.%至10wt.%,优选0.25wt.%至8wt.%,更优选0.5wt.%至5wt.%的量存在于该组合物中。
水相
本发明组合物包含至少一个水相。
根据一个优选实施方案,本发明组合物是水性糊状物。
根据本发明的组合物的水相包含水和任选的一种或多种水混溶性或至少部分水混溶性的化合物,例如C2-C8多元醇或一元醇,例如乙醇和异丙醇。
术语“多元醇”应理解为指包含至少两个游离羟基的任何有机分子。可以提及的多元醇的实例包括二元醇,例如丁二醇、丙二醇、一缩二丙二醇、异戊二醇、己二醇、辛乙二醇、丙三醇(即甘油)和聚乙二醇。
根据一个优选实施方案,根据本申请的组合物进一步包含至少一种C2-C8多元醇,其选自丁二醇、丙二醇、一缩二丙二醇、异戊二醇、己二醇、辛乙二醇、甘油和聚乙二醇。
在C2-C8多元醇的存在下,容易形成结晶体系。
优选地,相对于组合物的总重量计,C2-C8多元醇以30wt.%至40wt.%的量存在。
相对于组合物的总重量计,水相可占40wt.%至70wt.%,优选45wt.%至65wt.%。
另外的成分
根据本发明的组合物可包含一种或多种另外的成分,该成分选自在护肤清洁剂中常规使用的那些。
根据本发明的组合物可包含任何的以下添加剂:pH调节剂(例如柠檬酸);另外的表面活性剂;生物提取物;抗菌剂;香料;增稠剂;和阳离子防腐剂。
本领域技术人员可以通过常规操作的方式来调节存在于根据本发明的组合物中的另外的成分的类型和量,以使这些组合物的所需性质不受所述另外的成分的不利影响。
根据一个优选实施方案,本发明涉及用于清洁角蛋白材料和/或从角蛋白材料卸妆的组合物,相对于该组合物的总重量计,该组合物在水相中包含:
a)10wt.%至20wt.%的至少一种氨基酸表面活性剂,其选自月桂酰肌氨酸钠、椰油酰甘氨酸钠、椰油酰谷氨酸钠、硬脂酰谷氨酸钠、椰油酰谷氨酸二钠、月桂酰谷氨酸钠、椰油酰甘氨酸钾、椰油酰谷氨酸三乙醇胺、及其混合物;
b)选自0.8wt.%至5wt.%的至少一种C12-C24饱和一元醇;
c)0.5wt.%至3wt.%的至少一种二价金属盐和/或三价金属盐,其选自葡糖酸镁、PCA镁、硫酸镁、乙酸镁、碳酸镁、硅酸镁铝、碳酸钙、PCA钙、硅酸铝钙钠、氯化钙、碳酸钙、PCA锌、葡糖酸锌、PCA铜、葡糖酸铜、及其混合物;和
d)30wt.%至40wt.%的至少一种C2-C8多元醇,其选自丁二醇、丙二醇、一缩二丙二醇、异戊二醇、己二醇、辛乙二醇、甘油和聚乙二醇。
方法和用途
可通过施用到角蛋白材料而在用于清洁角蛋白材料(例如皮肤,尤其是面部)和/或从角蛋白材料(例如皮肤,尤其是面部)卸妆的方法中使用根据本发明的组合物。
根据本发明的组合物是结晶体系,其呈糊状物、霜或凝胶质地的乳液的形式。
根据本发明的组合物是温和且耐油的,并且没有滴落问题。
发现,根据本发明的组合物在施用后可提供好的泡沫密度、快的洗去速度和好的皮肤妆效(即不紧绷且不干燥的皮肤感觉、)。
根据本发明的组合物可以通过任何使得能够实现均匀分布的方式(尤其是使用手指或棉球)而施用,并且可以通过用水冲洗而除去。
因此,根据另一个方面,本发明涉及用于清洁角蛋白材料(尤其是皮肤)和/或从角蛋白材料(尤其是皮肤)卸妆的非治疗性方法,该方法包括将根据本发明的组合物施用到角蛋白材料(尤其是皮肤),以及在任选的时间段后洗去所述组合物。
通过以下描述的实施例更详细地例示本发明,所述实施例作为非限制性说明而给出。
实施例
所使用的主要原材料、及其商品名和供应商列于表1中。
表1
比较例1-3和发明例1-9
制备包含表2中所显示的成分的根据比较例(CE)1-3(CE)的组合物和根据发明例(IE)1-9的组合物,其中所有的量均由相对于各组合物的总重量计的活性物质的重量百分比来表示。
制备方法
以发明例1的组合物为例,如下制备组合物:
在搅拌下将椰油酰甘氨酸钠和甘油引入主釜中并加热至80℃。然后将水和柠檬酸预混合,以获得混合物,并在搅拌下将该混合物引入主釜中。接着,在搅拌下将葡糖酸镁、月桂醇和椰油酰胺基丙基甜菜碱逐一引入主釜中,以获得组合物,然后将该组合物冷却至室温。
组合物的评估
就质地、洗去速度、发泡密度和耐油性而言对所制备的组合物进行评估。
质地
观察到,发明例1-9的组合物呈霜的形式,并且不存在滴落问题。
洗去速度
洗去速度用来定义在整个面部出现最强的嘎吱作响感觉(squeaky feeling)的快速度,并如下所测试:
a)在自来水下冲洗双手2秒,在面部上移动湿的双手(不在手掌中存储水),从下巴移动到前额并返回到下巴(面部的两侧);
b)重复该冲洗过程15次;以及
c)用干毛巾干燥双手。
在15次冲洗动作期间,对发生嘎吱作响感觉的速度进行触觉评估。给出在1-15的范围内的评分,其中1-4表示低洗去速度,5-9表示中等洗去速度,且10-15表示高洗去速度。
发泡密度
泡沫密度指示泡沫品质的紧密度。
制备:用注射器取0.5ml的待测试的组合物,用移液管取3x1ml的水。
过程:
1)用自来水冲洗双手2秒,并用注射器将0.5ml的待测试组合物置于手掌,用一根移液管添加1ml水;
2)进行20圈的来回移动(2圈/秒),并且如有必要,则暂停,以将泡沫聚集在手掌中以防止泡沫流动;
3)再次用一根移液管添加1ml水,并进行20圈的来回移动(2圈/秒),并且如有必要,则暂停,以将泡沫聚集在手掌中以防止泡沫流动;
4)将所有泡沫一起放在一只手掌中。
给出在1-15的范围内的评分,其中1-4表示低泡沫密度,5-9表示中等泡沫密度,且10-15表示高泡沫密度。
发泡体积和耐油性
通过以下方式来测定发泡密度:将20g样品在有或无0.7g人造皮脂的情况下溶解于80g的自来水中,其具有表2中的下列组成,用厨房搅拌器搅拌2分钟,并然后用量筒测量泡沫体积。对每个样品进行3次测试,并对结果取平均值。
表2
/>
通过根据下式计算体积减少百分比(V减少%)来确定耐油性:
V减少%=[V(无皮脂)-V(有皮脂)]/V(无皮脂)*100%
如果体积减少百分比在30%-100%的范围中,则其意味着耐油性差。如果体积减少百分比在0%-15%的范围中,则其意味着耐油性好。
所获得的结果也总结在表3中。
表3
*最大值=15,越高越好
从表3中可见,与比较例1的组合物相比,发明例1-9的组合物显示更好的泡沫密度。
与比较例2和3的组合物相比,发明例1-9的组合物显示更好的洗去性质。
发明例1-2和5-9的组合物表明好的耐油性。
在洗去速度的测试期间,发现发明例1-9的组合物提供好的皮肤妆效(不紧绷且不干燥的皮肤感觉),并且对面部不产生刺激。
Claims (15)
1.一种用于清洁角蛋白材料和/或从角蛋白材料卸妆的组合物,所述组合物在水相中包含:
a)至少一种氨基酸表面活性剂;
b)至少一种C12-C24饱和一元醇;和
c)至少一种二价金属盐和/或三价金属盐。
2.根据权利要求1所述的组合物,其中所述氨基酸表面活性剂由式(I)代表:
其中:
Z代表具有8至22个碳原子的饱和或不饱和的直链或支链烃基,
X是氢或甲基,
n是0或1,
Y选自氢、-CH3、-CH(CH3)2、-CH2CH(CH3)2、-CH(CH3)CH2CH3、-CH2C6H5、-CH2C2H4OH、-CH2OH、-CH(OH)CH3、-(CH2)4NH2、-(CH2)3NHC(NH)NH2、-CH2C(O)O-M+、-(CH2)2C(O)OH、-(CH2)2C(O)O-M+,且
M是其中COO为抗衡阴离子的成盐阳离子,例如钠、钾、铵或三乙醇胺,
优选地,在式(I)中:
Z代表饱和或不饱和的直链或支链C8-C22烷基,
X是氢或甲基,
n是0,
Y选自氢、-(CH2)2C(O)OH、-(CH2)2C(O)O-M+,且
M是其中COO为抗衡阴离子的成盐阳离子,例如钠、钾、铵或三乙醇胺。
3.根据权利要求1或2所述的组合物,其中所述氨基酸表面活性剂选自月桂酰肌氨酸钠、椰油酰甘氨酸钠、椰油酰谷氨酸钠、硬脂酰谷氨酸钠、椰油酰谷氨酸二钠、月桂酰谷氨酸钠、椰油酰甘氨酸钾、椰油酰谷氨酸三乙醇胺、及其混合物。
4.根据权利要求1至3中任一项所述的组合物,其中相对于所述组合物的总重量计,所述氨基酸表面活性剂以3wt.%至50wt.%,优选5wt.%至30wt.%,更优选10wt.%至20wt.%的量存在。
5.根据权利要求1至4中任一项所述的组合物,其中所述C12-C24饱和一元醇选自鲸蜡醇、硬脂醇、鲸蜡硬脂醇、肉豆蔻醇、月桂醇、十三烷醇、十五烷醇、十六烷醇、花生醇和山萮醇。
6.根据权利要求1至5中任一项所述的组合物,其中相对于所述组合物的总重量计,所述C12-C24饱和一元醇以0.3wt.%至10wt.%,优选0.5wt.%至8wt.%,更优选0.8wt.%至5wt.%的量存在。
7.根据权利要求1至6中任一项所述的组合物,其中所述金属盐包含金属离子M1n+,其选自Mg2+、Ca2+、Zn2+、Fe2+、Mn2+、Cu2+、Al3+和Fe3+。
8.根据权利要求1至7中任一项所述的组合物,其中相对于所述组合物的总重量计,所述金属盐以0.25wt.%至10wt.%,优选0.25wt.%至5wt.%,更优选0.5wt.%至3wt.%的量存在。
9.根据权利要求1至8中任一项所述的组合物,其进一步包含至少一种两性表面活性剂,所述两性表面活性剂选自(C12-C20)烷基酰胺基(C1-C6)烷基甜菜碱,优选地,所述两性表面活性剂是椰油酰胺基丙基甜菜碱。
10.根据权利要求9所述的组合物,相对于所述组合物的总重量计,所述两性表面活性剂以0.5wt.%至10wt.%,优选0.25wt.%至8wt.%,更优选0.5wt.%至5wt.%的量存在。
11.根据权利要求1至10中任一项所述的组合物,其进一步包含至少一种C2-C8多元醇,所述C2-C8多元醇选自丁二醇、丙二醇、一缩二丙二醇、异戊二醇、己二醇、辛乙二醇、甘油和聚乙二醇。
12.根据权利要求11所述的组合物,其中相对于所述组合物的总重量计,所述C2-C8多元醇以30wt.%至40wt.%的量存在。
13.根据权利要求1至12中任一项所述的组合物,其中相对于所述组合物的总重量计,所述水相占40wt.%至70wt.%,优选45wt.%至65wt.%。
14.根据权利要求1至13中任一项所述的组合物,其中所述组合物是呈糊状物、霜或凝胶质地的乳液的结晶体系。
15.一种用于清洁角蛋白材料尤其是皮肤或头发和/或从角蛋白材料尤其是皮肤或头发卸妆的非治疗性方法,其包括将根据权利要求1-14中任一项所述的组合物施用到所述角蛋白材料,尤其是皮肤或头发,以及在任选的时间段后洗去所述组合物。
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2021/096044 WO2022246687A1 (en) | 2021-05-26 | 2021-05-26 | Composition for cleansing and/or removing makeups from keratin materials |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117377459A true CN117377459A (zh) | 2024-01-09 |
Family
ID=84229315
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202180098636.2A Pending CN117377459A (zh) | 2021-05-26 | 2021-05-26 | 用于清洁角蛋白材料和/或从角蛋白材料卸妆的组合物 |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP4346752A1 (zh) |
CN (1) | CN117377459A (zh) |
FR (1) | FR3123211B1 (zh) |
WO (1) | WO2022246687A1 (zh) |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU4482297A (en) * | 1997-09-17 | 1999-04-05 | Procter & Gamble Company, The | Hair care compositions comprising bulky optical brighteners |
AU4646997A (en) * | 1997-09-17 | 1999-04-05 | Procter & Gamble Company, The | Shampoo composition comprising triazoles |
JP4589865B2 (ja) * | 2002-10-09 | 2010-12-01 | 花王株式会社 | N−アセチルグルコサミン誘導体、及びその用途 |
US7297668B2 (en) * | 2003-04-03 | 2007-11-20 | Colgate-Palmolive Company | Composition |
EP1716842B1 (en) * | 2005-04-30 | 2008-12-24 | Cognis IP Management GmbH | Mild cleansing compositions |
US20080200704A1 (en) | 2007-02-20 | 2008-08-21 | Multi Formulations Ltd. | Preparation of amino acid-fatty acid amides |
JP5994790B2 (ja) * | 2011-11-30 | 2016-09-21 | 味の素株式会社 | 美白化粧料 |
DE102011089340A1 (de) * | 2011-12-21 | 2013-06-27 | Henkel Ag & Co. Kgaa | PEG-freie Antitranspirant-Öl-in-Wasser-Emulsionen mit verbesserter Haptik |
EP2821469B1 (en) * | 2013-07-02 | 2018-03-14 | The Procter & Gamble Company | Liquid cleaning and/or cleansing composition |
EP3324926B1 (en) * | 2015-07-22 | 2020-07-01 | L'Oréal | Composition for cleansing keratin material containing amino acid surfactant |
EP3386475B1 (en) * | 2015-12-10 | 2022-08-31 | L'oreal | Composition for cleansing keratin materials with improved rinsing properties |
CN111542305A (zh) * | 2017-12-26 | 2020-08-14 | 莱雅公司 | 用于护理角蛋白材料的组合物、其方法和用途 |
CN108703903B (zh) * | 2018-06-29 | 2021-04-13 | 安婕妤化妆品科技股份有限公司 | 一种美白祛斑精华液 |
US20220047496A1 (en) * | 2018-10-30 | 2022-02-17 | L'oreal | Cosmetic composition for skin care |
JP7353753B2 (ja) * | 2018-12-11 | 2023-10-02 | ロレアル | エーテル油を含む水中油型エマルション組成物 |
CN113873988B (zh) * | 2019-05-31 | 2023-10-03 | 莱雅公司 | 用于清洁角蛋白材料的组合物 |
CN112120980A (zh) * | 2020-09-22 | 2020-12-25 | 沧州明辰生物科技有限公司 | 一种固本培元洗发露及其制作方法 |
-
2021
- 2021-05-26 EP EP21942268.0A patent/EP4346752A1/en active Pending
- 2021-05-26 WO PCT/CN2021/096044 patent/WO2022246687A1/en active Application Filing
- 2021-05-26 CN CN202180098636.2A patent/CN117377459A/zh active Pending
- 2021-06-24 FR FR2106744A patent/FR3123211B1/fr active Active
Also Published As
Publication number | Publication date |
---|---|
FR3123211B1 (fr) | 2024-01-12 |
WO2022246687A1 (en) | 2022-12-01 |
EP4346752A1 (en) | 2024-04-10 |
FR3123211A1 (fr) | 2022-12-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3324926B1 (en) | Composition for cleansing keratin material containing amino acid surfactant | |
CN111542307B (zh) | 用于护理角蛋白材料的组合物、其方法和用途 | |
JP3304646B2 (ja) | 洗浄剤組成物 | |
CN117377459A (zh) | 用于清洁角蛋白材料和/或从角蛋白材料卸妆的组合物 | |
CN113873988B (zh) | 用于清洁角蛋白材料的组合物 | |
WO2019126998A1 (en) | Composition for caring for keratin materials, method and use thereof | |
JP4542279B2 (ja) | 洗浄用組成物 | |
JP3622267B2 (ja) | 洗浄剤組成物 | |
WO2022061556A1 (en) | Composition for cleansing and/or removing makeups from keratin materials | |
CN117500476A (zh) | 用于清洁角蛋白材料和/或从角蛋白材料卸妆的组合物 | |
JP2839897B2 (ja) | 皮膚洗浄剤組成物 | |
JP2024520159A (ja) | ケラチン物質をクレンジングする及び/又はケラチン物質からメイクアップを除去するための組成物 | |
KR101062626B1 (ko) | 세정제 조성물 | |
JP2020164430A (ja) | パーソナルケア組成物 | |
JP7364502B2 (ja) | 皮膚洗浄剤組成物 | |
JP3296018B2 (ja) | 洗浄剤組成物 | |
CN113395957A (zh) | 用于清洁角蛋白材料的组合物 | |
JPH059495A (ja) | 洗浄剤組成物 | |
CN115298296A (zh) | 通过使用糖类同分异构体提高洗涤剂组合物的发泡特性的方法 | |
JP2021155366A (ja) | 洗浄料組成物 | |
JPH06248298A (ja) | 身体用液状洗浄剤組成物 | |
JPH01294800A (ja) | 液体洗浄剤組成物 | |
JP2018043981A (ja) | 皮脂洗浄用組成物 | |
JPH08157350A (ja) | 身体用洗浄剤組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |